• Explore /
  • Poster
  • / Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or without tremelimumab (D+/-T) in head and neck squamous cell carcinoma (HNSCC).

Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or without tremelimumab (D+/-T) in head and neck squamous cell carcinoma (HNSCC).

Abstract Poster

Authors

null

Hyunwook Kim

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

Hyunwook Kim , Yoon Woo Koh , Hyun Jun Hong , DaHee Kim , Nam Suk Sim , Hye Ryun Kim , Min Hee Hong , Chang Gon Kim , Chang Lee , Kyung Hwan Kim , Mingu Kang , Heon Song , Chiyoon Oum , Seulki Kim , Yoojoo Lim , Chan-Young Ock , Sun Och Yoon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

New Targets and New Technologies (IO)

Clinical Trial Registration Number

NCT03737968

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2578)

DOI

10.1200/JCO.2023.41.16_suppl.2578

Abstract #

2578

Poster Bd #

420

Abstract Disclosures

Similar Posters

First Author: Hongjae Chon

First Author: Chiyoon Oum

First Author: Gahee Park

First Author: Chang Gon Kim